Learn More
To the Editor, Gastric cancer is the third most common cause of cancer-related deaths in both sexes worldwide. Helicobacter pylori infection is the greatest known risk factor for the development of gastric cancer. H. pylori can cause chronic active gastritis and atrophic gastritis by producing persistent acute-on-chronic inflammation. Therefore, screening(More)
INTRODUCTION Systemic inflammation, endothelial dysfunction and arterial thickening contribute to the elevated cardiovascular risk of dialysis patients. However, the course of these derangements and their relative contribution to the cardiovascular risk of nondialysed chronic kidney disease (CKD) are scarcely investigated. METHODS Flow-mediated dilatation(More)
Objective. The aim of the present study was to investigate whether pentraxin 3 (PTX3) can be a new noninvasive marker for prediction of liver fibrosis in patients with NAFLD. We also aimed to evaluate the relationship between PTX3 and atherosclerosis in patients with NAFLD. Method. Fifty-four male patients with biopsy-proven NAFLD and 20 apparently healthy(More)
Sarcopenia has increasingly been proposed as a predictor of response to treatment in oncology patients. In the August 2015 issue of The Oncologist, Arrieta et al. reported that routinely screening for sarcopenia and nutritional status was helpful in determining the next step of chemotherapy as well as toxicities in patients with non-small cell lung cancer(More)
To the Editor: We read the article of Chung et al., 1 " The efficacy of moxiflo-xacin-containing triple therapy after standard triple, sequential , or concomitant therapy failure for Helicobacter pylori eradication in Korea " with great interest. In this very well-designed study, the authors found that the eradication rate with moxifloxacin-containing(More)
  • 1